CN218391795U - Anti-puncture insulin injection device - Google Patents
Anti-puncture insulin injection device Download PDFInfo
- Publication number
- CN218391795U CN218391795U CN202221691585.2U CN202221691585U CN218391795U CN 218391795 U CN218391795 U CN 218391795U CN 202221691585 U CN202221691585 U CN 202221691585U CN 218391795 U CN218391795 U CN 218391795U
- Authority
- CN
- China
- Prior art keywords
- needle
- stab
- injection device
- insulin injection
- insulin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 84
- 238000002347 injection Methods 0.000 title claims abstract description 76
- 239000007924 injection Substances 0.000 title claims abstract description 76
- 102000004877 Insulin Human genes 0.000 title claims abstract description 42
- 108090001061 Insulin Proteins 0.000 title claims abstract description 42
- 229940125396 insulin Drugs 0.000 title claims abstract description 42
- 229920000742 Cotton Polymers 0.000 claims description 6
- 239000011111 cardboard Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 4
- 239000004033 plastic Substances 0.000 claims description 3
- 229920001296 polysiloxane Polymers 0.000 claims description 3
- 230000006978 adaptation Effects 0.000 claims 1
- 238000009434 installation Methods 0.000 abstract description 2
- ORMNNUPLFAPCFD-DVLYDCSHSA-M phenethicillin potassium Chemical compound [K+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C(C)OC1=CC=CC=C1 ORMNNUPLFAPCFD-DVLYDCSHSA-M 0.000 description 24
- 239000000243 solution Substances 0.000 description 15
- 230000006378 damage Effects 0.000 description 6
- 210000003811 finger Anatomy 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 229940127560 insulin pen Drugs 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
技术领域technical field
本公开涉及医疗器械技术领域,尤其是涉及一种防刺伤胰岛素注射装置。The disclosure relates to the technical field of medical devices, in particular to a stab-proof insulin injection device.
背景技术Background technique
胰岛素是有胰岛内的胰岛β细胞受内源性或外源性物质如葡萄糖、乳糖、核糖、精氨酸、胰高血糖素等的刺激而分泌的一种蛋白质激素,胰岛素是体内唯一降低血糖的激素。同时促进糖原、脂肪、蛋白质合成,外源性胰岛素主要用来治疗糖尿病。胰岛素用于治疗大多数类型的糖尿病,一般而言,是否需要胰岛素治疗取决于胰岛素缺乏程度,所有1型糖尿病患者都需接收胰岛素治疗;很多2型糖尿病患者会随着β细胞功能逐渐减退而需要胰岛素。而在对糖尿病患者注射药物的治疗这种,糖尿病患者或者糖尿病患者的保护者每天需要向患者体内注射 2-3次胰岛素,这时患者可以将胰岛素的药液放到胰岛素注射笔的笔芯当中,装上特定的推动装置之后,在注射之前拧上无菌的注射针头,然后通过一系列的操作,从而将胰岛素准确的注射到体内。但现有的胰岛素笔在使用时,注射针头与胰岛素笔是通过螺纹连接,胰岛素针头在使用时,需要医护人员手动将胰岛素针头卸下胰岛素笔,将胰岛素针头拆卸的过程中,胰岛素针头容易刺伤医护人员,尤其在患者使用结束后,注射针头上携带有各种病菌,使医护人员暴露在病菌面前,不仅容易给医护人员造成伤害,亦带来较大的心理负担。Insulin is a protein hormone secreted by pancreatic β cells in the islets stimulated by endogenous or exogenous substances such as glucose, lactose, ribose, arginine, glucagon, etc. Insulin is the only one in the body that lowers blood sugar hormones. At the same time, it promotes the synthesis of glycogen, fat and protein, and exogenous insulin is mainly used to treat diabetes. Insulin is used to treat most types of diabetes. In general, the need for insulin therapy depends on the degree of insulin deficiency. All patients with type 1 diabetes receive insulin therapy; many patients with type 2 diabetes will need insulin as the beta cell function gradually declines insulin. In the treatment of diabetic patients injecting drugs, diabetic patients or their protectors need to inject insulin 2-3 times a day into the patient's body. At this time, the patient can put the insulin liquid into the refill of the insulin injection pen. , After installing a specific push device, screw on a sterile injection needle before injection, and then through a series of operations, insulin can be accurately injected into the body. However, when the existing insulin pen is in use, the injection needle and the insulin pen are connected by threads. When the insulin needle is in use, medical personnel need to manually remove the insulin needle from the insulin pen. Injury to medical staff, especially after the patient has finished using it, the injection needle carries various germs, exposing the medical staff to the germs, which not only easily causes injury to the medical staff, but also brings a greater psychological burden.
因此,本公开提供了一种防刺伤胰岛素注射装置,以解决现有胰岛素笔针头容易刺伤医护人员的问题。Therefore, the present disclosure provides a stab-proof insulin injection device to solve the problem that the needles of existing insulin pens are easy to stab the medical staff.
实用新型内容Utility model content
本公开提供了一种防刺伤胰岛素注射装置,以解决发明人认识到的现有胰岛素笔针头容易刺伤医护人员的技术问题。The present disclosure provides a stab-proof insulin injection device to solve the technical problem recognized by the inventors that the needles of existing insulin pens are easy to stab medical staff.
本公开提供了一种防刺伤胰岛素注射装置,包括:The present disclosure provides a stab-proof insulin injection device, comprising:
针头,所述针头包括针座和针筒,所述针座的外侧对称设置有两个固定杆,所述固定杆上活动安装有卡件,所述卡件被配置为供使用者推动后与所述针筒相卡接;Needle head, the needle head includes a needle base and a needle cylinder, two fixed rods are symmetrically arranged on the outside of the needle base, and a clamp is movably installed on the fixed rod, and the clamp is configured to be pushed by the user to connect with the The syringes are snapped together;
注射笔,所述针座与所述注射笔的一端可拆卸连接。An injection pen, wherein the needle seat is detachably connected to one end of the injection pen.
在上述任一技术方案中,进一步地,所述卡件包括转轴、连接架和卡板,所述转轴的数量的设置为两个,且两个所述转轴分别转动安装于两个所述固定杆上,所述转轴和所述卡板通过所述连接架相连接。In any of the above technical solutions, further, the clip includes a rotating shaft, a connecting frame and a clamping plate, the number of the rotating shafts is set to two, and the two rotating shafts are respectively rotatably mounted on the two fixed On the rod, the rotating shaft and the clamping plate are connected through the connecting frame.
在上述任一技术方案中,进一步地,所述卡板的外侧设置有接触部,所述接触部为用于容置使用者手指的凹槽结构,所述卡板的内侧设置有棉垫。In any of the above technical solutions, further, a contact portion is provided on the outside of the clamp, and the contact portion is a groove structure for accommodating a user's finger, and a cotton pad is provided on the inside of the clamp.
在上述任一技术方案中,进一步地,所述卡板具有相对的首端和尾端,所述卡板的首端与所述卡板的尾端呈角度设置。In any of the above technical solutions, further, the clamping board has a head end and a tail end opposite to each other, and the head end of the clamping board and the tail end of the clamping board are arranged at an angle.
在上述任一技术方案中,进一步地,所述固定杆的端部为半球状。In any of the above technical solutions, further, the end of the fixing rod is hemispherical.
在上述任一技术方案中,进一步地,还包括置于所述注射笔上的套杆,所述套杆上开设有卡槽,所述固定杆的端部适配于所述卡槽。In any of the above technical solutions, further, it further includes a sleeve rod placed on the injection pen, the sleeve rod is provided with a slot, and the end of the fixing rod is adapted to the slot.
在上述任一技术方案中,进一步地,所述套杆内设置有内螺纹,所述注射笔的外侧设置有外螺纹,所述内螺纹与所述外螺纹适配。In any of the above technical solutions, further, the sleeve rod is provided with internal threads, and the outer side of the injection pen is provided with external threads, and the internal threads are adapted to the external threads.
在上述任一技术方案中,进一步地,所述注射笔的外侧开设有用于防止所述套杆脱落的通槽。In any of the above technical solutions, further, a through groove for preventing the sleeve rod from falling off is formed on the outside of the injection pen.
在上述任一技术方案中,进一步地,所述套杆整体的材质为塑料、橡胶或硅胶中的其中之一。In any of the above technical solutions, further, the overall material of the sleeve rod is one of plastic, rubber or silicone.
在上述任一技术方案中,进一步地,还包括针帽,所述针帽相对的两侧设置有凸起部分,所述凸起部分上开设有用于容置所述固定杆的滑槽。In any one of the above technical solutions, further comprising a needle cap, protruding parts are provided on opposite sides of the needle cap, and sliding slots for accommodating the fixing rod are opened on the protruding parts.
本公开的有益效果主要在于:The beneficial effects of the present disclosure mainly lie in:
1.本公开通过针座、针筒、固定杆、卡件、注射笔的设计,将针头与注射笔通过螺纹可拆卸连接,实现胰岛素注射功能;利用卡件与固定杆转动安装,以使使用者通过外力驱动卡件绕于固定杆旋转,以使卡件与针筒的尖锐端部卡接,进而避免使用者一次放针头刺伤。1. Through the design of the needle base, syringe, fixing rod, clamp and injection pen, the needle and the injection pen are detachably connected by threads to realize the insulin injection function; The clamp is driven by an external force to rotate around the fixed rod, so that the clamp is engaged with the sharp end of the syringe, thereby preventing the user from being stabbed by the needle once.
2.本公开通过固定杆、卡件的设计,通过设置符合人体手指的接触部,方便使用者推动卡件;在将卡板的内侧与针筒的尖锐端向卡接时,相当于针筒的尖锐端插入至卡板的内侧,进而在正常状态下,卡板与针筒不会脱离,进而避免针头对使用造成刺伤。2. Through the design of the fixing rod and the clip, the present disclosure facilitates the user to push the clip by setting the contact part conforming to the finger of the human body; when the inside of the clip is connected to the sharp end of the syringe, it is equivalent to the needle barrel The sharp end of the needle is inserted into the inner side of the card board, and under normal conditions, the card board and the syringe will not be separated, thereby preventing the needle from being stabbed in use.
3.本公开通过套杆的设计,将套杆与注射笔拆分后,利用卡槽与固定杆卡接后,通过旋转套杆以带动针头旋转,进而将针头通过套杆在注射笔上取下,防止使用者在拆卸针头时直接与针头相接触,进一步防止针头对使用者造成刺伤伤害,即防止针头的二次刺伤。3. Through the design of the set rod, the present disclosure separates the set rod from the injection pen, and then connects it with the fixed rod by using the slot, then rotates the set rod to drive the rotation of the needle, and then removes the needle from the injection pen through the set rod. Next, prevent the user from directly contacting the needle when disassembling the needle, and further prevent the needle from causing a stabbing injury to the user, that is, prevent the secondary stabbing of the needle.
应当理解,前述的一般描述和接下来的具体实施方式两者均是为了举例和说明的目的并且未必限制本公开。并入并构成说明书的一部分的附图示出本公开的主题。同时,说明书和附图用来解释本公开的原理。It is to be understood that both the foregoing general description and the following detailed description are for purposes of illustration and description and are not necessarily restrictive of the disclosure. The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate subject matter of the present disclosure. Meanwhile, the specification and drawings serve to explain the principles of the present disclosure.
附图说明Description of drawings
为了更清楚地说明本公开具体实施方式或现有技术中的技术方案,下面将对具体实施方式或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图是本公开的一些实施方式,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the specific embodiments of the present disclosure or the technical solutions in the prior art, the following will briefly introduce the drawings that need to be used in the description of the specific embodiments or the prior art. Obviously, the accompanying drawings in the following description The drawings are some implementations of the present disclosure, and those skilled in the art can also obtain other drawings according to these drawings without creative work.
图1为本公开实施例的整体结构平面示意图;FIG. 1 is a schematic plan view of the overall structure of an embodiment of the present disclosure;
图2为本公开实施例的注射笔结构平面示意图;Fig. 2 is a schematic plan view of the structure of the injection pen according to the embodiment of the present disclosure;
图3为本公开实施例的针头结构平面示意图;Fig. 3 is a schematic plan view of the needle structure of the embodiment of the present disclosure;
图4为本公开实施例的整体结构俯视示意图;4 is a schematic top view of the overall structure of an embodiment of the present disclosure;
图5为本公开实施例的套杆平面示意图。FIG. 5 is a schematic plan view of a sleeve rod according to an embodiment of the present disclosure.
图标:icon:
100-针头;101-针座;102-针筒;103-卡件;104-转轴;105- 连接架;106-卡板;107-接触部;108-套杆;109-卡槽;110-内螺纹;111-针帽;112-滑槽;200-注射笔;201-外螺纹;202-通槽;300-固定杆。100-needle head; 101-needle seat; 102-needle cylinder; 103-clamp; 104-rotating shaft; 105-connecting frame; Internal thread; 111-needle cap; 112-chute; 200-injection pen; 201-external thread; 202-through groove; 300-fixing rod.
具体实施方式Detailed ways
下面将结合附图对本公开的技术方案进行清楚、完整地描述,显然,所描述的实施例是本公开一部分实施例,而不是全部的实施例。The technical solutions of the present disclosure will be clearly and completely described below in conjunction with the accompanying drawings. Apparently, the described embodiments are some of the embodiments of the present disclosure, rather than all of them.
基于本公开中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本公开保护的范围。Based on the embodiments in the present disclosure, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present disclosure.
在本公开的描述中,需要说明的是,术语“中心”、“上”、“下”、“左”、“右”、“竖直”、“水平”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本公开和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本公开的限制。此外,术语“第一”、“第二”、“第三”仅用于描述目的,而不能理解为指示或暗示相对重要性。In the description of the present disclosure, it should be noted that the terms "center", "upper", "lower", "left", "right", "vertical", "horizontal", "inner", "outer" etc. The indicated orientation or positional relationship is based on the orientation or positional relationship shown in the drawings, and is only for the convenience of describing the present disclosure and simplifying the description, rather than indicating or implying that the referred device or element must have a specific orientation, or in a specific orientation. construction and operation are therefore not to be construed as limitations on the present disclosure. In addition, the terms "first", "second", and "third" are used for descriptive purposes only, and should not be construed as indicating or implying relative importance.
在本公开的描述中,需要说明的是,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是机械连接,也可以是电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本公开中的具体含义。In the description of the present disclosure, it should be noted that unless otherwise specified and limited, the terms "installation", "connection" and "connection" should be understood in a broad sense, for example, it can be a fixed connection or a detachable connection. Connected, or integrally connected; it can be mechanically connected or electrically connected; it can be directly connected or indirectly connected through an intermediary, and it can be the internal communication of two components. Those of ordinary skill in the art can understand the specific meanings of the above terms in the present disclosure in specific situations.
请参阅图1、图2、图3和图4,在一个或多个实施例中,本公开提供了一种防刺伤胰岛素注射装置,包括针头100和注射笔200,针头100包括针座101和针筒102,针座101的外侧对称设置有两个固定杆300,固定杆300上活动安装有卡件103,卡件103被配置为供使用者推动后与针筒102相卡接;针座101 与注射笔200的一端可拆卸连接。Referring to FIG. 1 , FIG. 2 , FIG. 3 and FIG. 4 , in one or more embodiments, the present disclosure provides a stab-resistant insulin injection device, including a
具体而言,注射笔200包括笔帽、笔芯、笔身,在笔身上设置有苦读、显示窗、剂量选择旋钮、剂量指示和注射推键,其具体的工作原理为:在2-8℃冰箱中拿出注射笔200,放置常温,一手持笔帽,另一手持笔身轻轻地往外拉,以摘下笔帽;取一个新的一次性针头100,揭掉针头100上的保护片,直接将针头100与笔身拧紧;取下针头100的外帽;调节剂量选择旋钮直至气流检查标志对准指针,0刻度后一个刻度,无数字显示,专门排气用;握住注射笔200,并使针尖向上,用手指轻弹笔杆数下,以使气泡均向上聚集至笔芯顶部;保持针尖向上,充分推压注射推键,使剂量刻度回到0刻度,针尖应出现一滴胰岛素,如果无液滴出现,重复以上两步骤,但不能超过 4次,如果仍未出现胰岛素液滴,即需更换针头100或更换注射笔200;调节剂量旋钮,使剂量指示在注射的剂量,一般胰岛素刻度为数字,代表是单位,一直笔芯3ml共有300单位,根据治疗需要旋转至治疗量;注射时应将注射推键完全按下,直到剂量指示到0刻度,注意在注射期间勿使其他手指触到显示窗或在侧方按下剂量选择旋钮,以避免注射被阻止;拔出针头100即可。需要说明的是,本实施例中所述的卡件103与针筒102的尖锐部分卡接可以理解为,针筒102的尖锐端插入至卡件103,此时卡件103与针筒102相对固定。Specifically, the
本公开通过针座101、针筒102、固定杆300、卡件103、注射笔200的设计,将针头100与注射笔200通过螺纹可拆卸连接,实现胰岛素注射功能;利用卡件103与固定杆300转动安装,以使使用者通过外力驱动卡件103绕于固定杆300旋转,以使卡件103与针筒102的尖锐端部卡接,进而避免使用者一次放针头100刺伤。In this disclosure, through the design of the
请参阅图1、图2、图3和图4,在上述实施例中,卡件103 包括转轴104、连接架105和卡板106,转轴104的数量的设置为两个,且两个转轴104分别转动安装于两个固定杆300上,转轴104和卡板106通过连接架105相连接;卡板106的外侧设置有接触部107,接触部107为用于容置使用者手指的凹槽结构,卡板106的内侧设置有棉垫;卡板106具有相对的首端和尾端,卡板106的首端与卡板106的尾端呈角度设置,以有利于卡板106的首端与针筒102的端部卡接。具体而言,两个转轴104分别转动安装于两个固定杆300上,连接架105的两端分别与两个转轴104固定连接,卡板106固定安装于连接架 105上;卡板106的外侧的凹槽结构至少能够容置使用者的大拇指,卡板106的内侧设置为棉垫,有利于针筒102尖锐的部分与卡板106卡接时的牢固性。需要说明的是,本实施例中所述的卡板106与针筒102的尖锐部分卡接可以理解为,针筒102 的尖锐端插入至卡板106的棉垫上,此时卡板106与针筒102 相对固定。Referring to Fig. 1, Fig. 2, Fig. 3 and Fig. 4, in the above embodiment, the
本公开通过固定杆300、卡件103的设计,通过设置符合人体手指的接触部107,方便使用者推动卡件103;在将卡板 106的内侧与针筒102的尖锐端向卡接时,相当于针筒102的尖锐端插入至卡板106的内侧,进而在正常状态下,卡板106 与针筒102不会脱离,进而避免针头100对使用造成刺伤。In this disclosure, through the design of the fixing
需要说明的是,在病房中使用胰岛素针注射时,一般病房会配备利器盒,在注射完成后,一般将针头100拆卸下后放置在利器盒内,但不免会有利器盒被拿走倾倒、消毒处理等情况发生,因此通过将卡件103与针头100卡接后,可以暂时将针头100放置在污染碗、柜子等位置,而避免针头100对其他人员造成损伤。It should be noted that when insulin needles are used for injection in the ward, the general ward will be equipped with a sharps box. After the injection is completed, the
请参阅图1、图3、图4和图5,在一些实施例中,还包括置于注射笔200上的套杆108,套杆108上开设有卡槽109,固定杆300的端部为半球状,固定杆300的端部适配于卡槽109;套杆108内设置有内螺纹110,注射笔200的外侧设置有外螺纹201,内螺纹110与外螺纹201适配;注射笔200的外侧开设有用于防止套杆108脱落的通槽202,在具体实施中,由于内螺纹110相对套管的内侧壁为凸出状,因此注射笔200通槽 202的径向小于注射笔200的径向,以防止套杆108脱落于注射笔200;套杆108整体的材质为塑料、橡胶或硅胶中的其中之一,利用其材质的透明性质,方便使用者观察卡槽109的位置。具体而言,卡槽109的长度至少大于针筒102尖锐端至针座101底面的长度;套杆108的内螺纹110与注射笔200的外螺纹201相连接时,套杆108的底端至注射笔200的底端具有一定的距离,其距离大于或等于卡槽109的长度。Please refer to Fig. 1, Fig. 3, Fig. 4 and Fig. 5, in some embodiments, it also includes a
本公开通过套杆108的设计,将套杆108与注射笔200拆分后,利用卡槽109与固定杆300卡接后,通过旋转套杆108 以带动针头100旋转,进而将针头100通过套杆108在注射笔 200上取下,防止使用者在拆卸针头100时直接与针头100相接触,进一步防止针头100对使用者造成刺伤伤害,即防止针头100的二次刺伤。In the present disclosure, through the design of the
请参阅图1,在一些实施例中,还包括针帽111,针帽111 相对的两侧设置有凸起部分,凸起部分上开设有用于容置固定杆300的滑槽112。在使用时,使用者手持针帽111向外拉动,即滑槽112沿着固定杆300向外滑动,以拆分针帽111和针头 100。Please refer to FIG. 1 , in some embodiments, a needle cap 111 is further included. Protruding portions are provided on opposite sides of the needle cap 111 , and sliding
具体的,本公开提供的一种防刺伤胰岛素注射装置的工作原理为:Specifically, the working principle of a stab-proof insulin injection device provided by the present disclosure is as follows:
使用者大拇指按住接触部107绕于固定杆300旋转,令针筒102的尖锐端插入至卡板106的棉垫上,即可实现对针头100 的保护,即避免针头100对使用者造成损伤;The user's thumb presses the
沿着注射笔200的轴向向下旋转套杆108,令套杆108的内螺纹110与注射笔200的外螺纹201相拆分;利用套杆108 的透明性质,手动控制套杆108的卡槽109与固定杆300相卡接,沿着注射笔200的轴向垂直向下移动套杆108,以使固定杆300处于卡槽109的端部,此时可以视为套杆108将针头100 包裹住;反向旋转套杆108,进而套杆108带动固定杆300旋转,进而固定杆300带动针座101旋转,进而将针座101与注射笔200拆分,在通槽202的限制作用下,套杆108不会脱落于注射笔200;在将针头100处理完成后,沿着注射笔200的轴向向上旋转套杆108,令套杆108的内螺纹110与注射笔200 的外螺纹201相连接。Rotate the
最后应说明的是:以上各实施例仅用以说明本公开的技术方案,而非对其限制;尽管参照前述各实施例对本公开进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本公开各实施例技术方案的范围。Finally, it should be noted that: the above embodiments are only used to illustrate the technical solutions of the present disclosure, not to limit them; although the present disclosure has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: It is still possible to modify the technical solutions described in the foregoing embodiments, or perform equivalent replacements for some or all of the technical features; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the technical solutions of the various embodiments of the present disclosure. scope.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202221691585.2U CN218391795U (en) | 2022-06-30 | 2022-06-30 | Anti-puncture insulin injection device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202221691585.2U CN218391795U (en) | 2022-06-30 | 2022-06-30 | Anti-puncture insulin injection device |
Publications (1)
Publication Number | Publication Date |
---|---|
CN218391795U true CN218391795U (en) | 2023-01-31 |
Family
ID=85012756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202221691585.2U Active CN218391795U (en) | 2022-06-30 | 2022-06-30 | Anti-puncture insulin injection device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN218391795U (en) |
-
2022
- 2022-06-30 CN CN202221691585.2U patent/CN218391795U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327656A (en) | Disposable array miniature injection needle head | |
CN218391795U (en) | Anti-puncture insulin injection device | |
CN212973421U (en) | Puncture type neurology clinical treatment device | |
US11771842B2 (en) | Syringes, syringe containers, kits and methods of use | |
RU98920U1 (en) | SYSTEM FOR REPEATED SCREEN INTRODUCTION OF SOLUTION OF MEDICINES | |
US11497855B2 (en) | Smart drug injection device | |
CN213191791U (en) | An insulin syringe with protective function | |
CN211023765U (en) | Epidural anesthesia nursing instrument box | |
CN211272870U (en) | A syringe for endocrinology | |
CN211096693U (en) | Syringe with hidden needle | |
CN209884917U (en) | Infusion port injection assistor | |
CN205434579U (en) | Pancreas transplantation operation is with insulin hypodermic device | |
CN210992315U (en) | An insulin injection disc | |
CN202342607U (en) | Disposable array type mini injection needle | |
CN113017845A (en) | Special anesthesia batch pan of anesthesiologist of conveniently taking medicine | |
CN219231009U (en) | An anti-stick type retention needle | |
CN221672996U (en) | Fixed auxiliary injection device | |
CN207980114U (en) | Arm holds formula syringe pump | |
CN209361533U (en) | A kind of novopen syringe-needle recovering device | |
CN217489436U (en) | A non-destructive needle protection device for infusion port | |
CN214435665U (en) | An injection positioning device for endocrinology | |
CN211434449U (en) | Insulin pen placing box | |
CN211584692U (en) | Insulin needle tube for infants | |
CN221845684U (en) | Infusion port puncture fixer | |
CN216318628U (en) | A medicine placing table with reminder function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |